TABLE 3

Follow-Up Closeout Data (February 2018)

ParameterData
Follow-up for entire study (mo)
 Median15 (range, 2–50)
 Mean ± SD19 ± 13
Follow-up for surviving patients (mo)
 Median26 (range, 6–50)
 Mean ± SD25 ± 13
PFS
 Median10 (range, 2–50)
 Mean ± SD17 ± 14
OS
 Median16 (range, 3–50)
 Mean ± SD20 ± 13
Local or distant recurrence (n)18 (45%)*
Death (n)18 (45%)†

  • ↵* 15 of these 18 patients died due to cancer progression.

  • ↵† During median follow-up of 11 mo (mean, 12 ± 8; range, 2–34).